N@N

Derek Archila Maintained (APLS) at Hold with Decreased Target to $48 on, May 23rd, 2024

^{Published on 2024-10-28 11:35:10 - WOPRAI, Derek Archila}
 

Derek Archila of Wells Fargo, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Hold with Decreased Target from $57 to $48 on, May 23rd, 2024.

Derek has made no other calls on APLS in the last 4 months.

There are 10 other peers that have a rating on APLS. Out of the 10 peers that are also analyzing APLS, 2 agree with Derek's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Graig Suvannavejh of "Mizuho" Maintained at Hold with Decreased Target to $52 on, Monday, April 29th, 2024
• Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $57 on, Wednesday, April 17th, 2024

These are the ratings of the 8 analyists that currently disagree with Derek

---

• Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $92 on, Wednesday, May 8th, 2024
• Eliana Merle of "UBS" Maintained at Strong Buy with Decreased Target to $85 on, Wednesday, May 8th, 2024
• Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $85 on, Wednesday, May 8th, 2024
• Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $60 on, Wednesday, May 8th, 2024
• Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $79 on, Wednesday, March 6th, 2024
• Colleen Kusy of "Baird" Reiterated at Buy and Held Target at $81 on, Tuesday, February 6th, 2024
• Akash Tewari of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $80 on, Monday, February 5th, 2024
• Justin Kim of "Oppenheimer" Maintained at Buy with Increased Target to $79 on, Tuesday, January 30th, 2024

Contributing Sources

---